Article Listing - Japan stock market week to April 27, 2009

NEG LIST TALKS CONTINUE IN SPAIN

27 April 1992

Talks are continuing between the Spanish Health Ministry and the Spanish pharmaceutical industry association, Farmaindustria, on the selective financing of...

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

US biotechnology company Bio-Technology General Corp has received approval to market Eskatrope, its recombinant version of human growth hormone which...

UPJOHN'S GLYNASE APPROVED IN USA

27 April 1992

Upjohn has received marketing approval from the US Food and Drug Administration for an improved formulation of its leading antidiabetic...

IMMUNOMEDICS PRESIDENT RESIGNS

27 April 1992

Russell McLauchlan has resigned as president of Immuno-medics. According to the company, a successor is expected to be announced by...

EUROCETUS TO MARKET PROLEUKIN

27 April 1992

US pharmaceutical company Chiron's Dutch subsidiary, EuroCetus BV, has received approval from the Austrian Board of Health to market Proleukin...

JAPAN'S 1st TYMPANIC THERMOMETER

27 April 1992

Japan's Tanabe Seiyaku Company and Omron Corp report that they have jointly developed a tympanic thermometer, the Quick Thermo MC-500,...

Japan FTC To Reduce Antitrust Exemptions

27 April 1992

Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...

GERMAN HEALTH COST DEBATE HOTS UP

27 April 1992

The debate as to how to control ever-rising German health care spending has intensified with controversial new proposals from the...

INST FARMA SERONO POSTS LOWER PROFITS

27 April 1992

Instituto Farmacologico Serono, which is listed on the Rome bourse, ended 1991 with 6.7 million lire ($5.4 million) profit, down...

ROMANIA INVESTMENT

27 April 1992

A recent communique issued by the Romanian government said that foreign investment in the country's pharmaceutical industry will be given...

Showing 94141-94150 of 95365 articles